中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2011年
23期
3208-3209
,共2页
脑出血%脑损伤%尼莫地平
腦齣血%腦損傷%尼莫地平
뇌출혈%뇌손상%니막지평
Cerebral hemorrhage%Brain injures%Nimodipine
目的 研究尼莫地平对脑出血后脑损害的保护作用.方法 62例脑出血后脑损伤患者随机分成两组,每组31例,对照组采用常规方法治疗,治疗组在对照组基础上采用尼莫地平治疗,疗程为l0 d.比较治疗前后两组患者的神经功能缺损评分、血肿体积、临床有效率.结果 治疗后,两组患者神经缺损评分均显著降低,治疗组下降更明显(P<0.05);两组患者血肿体积明显缩小,治疗组更明显(P<0.05);对照组总有效率为51.6%,治疗组总有效率为77.4%,两组差异有统计学意义(P<0.05).结论 尼莫地平对脑出血后脑损伤具有明显的保护作用,可改善神经功能,缩小血肿体积.
目的 研究尼莫地平對腦齣血後腦損害的保護作用.方法 62例腦齣血後腦損傷患者隨機分成兩組,每組31例,對照組採用常規方法治療,治療組在對照組基礎上採用尼莫地平治療,療程為l0 d.比較治療前後兩組患者的神經功能缺損評分、血腫體積、臨床有效率.結果 治療後,兩組患者神經缺損評分均顯著降低,治療組下降更明顯(P<0.05);兩組患者血腫體積明顯縮小,治療組更明顯(P<0.05);對照組總有效率為51.6%,治療組總有效率為77.4%,兩組差異有統計學意義(P<0.05).結論 尼莫地平對腦齣血後腦損傷具有明顯的保護作用,可改善神經功能,縮小血腫體積.
목적 연구니막지평대뇌출혈후뇌손해적보호작용.방법 62례뇌출혈후뇌손상환자수궤분성량조,매조31례,대조조채용상규방법치료,치료조재대조조기출상채용니막지평치료,료정위l0 d.비교치료전후량조환자적신경공능결손평분、혈종체적、림상유효솔.결과 치료후,량조환자신경결손평분균현저강저,치료조하강경명현(P<0.05);량조환자혈종체적명현축소,치료조경명현(P<0.05);대조조총유효솔위51.6%,치료조총유효솔위77.4%,량조차이유통계학의의(P<0.05).결론 니막지평대뇌출혈후뇌손상구유명현적보호작용,가개선신경공능,축소혈종체적.
Objective To study the protective effect of Nimodipine treatment of brain damage in patients with cerebral hemorrhage.Methods 62 cases of brain damage in patients with cerebral hemorrhage were divided into treatment group and control group,each for 31 cases.The control group were given conventional treatment,and the treatment group were given Nimodipine on the basis of the control group,treatment for 10d.NIHSS,hematoma volume and clinical effective rate were compared.Results After treatment,the NIHSS was lower between two groups,the treatment group decline was more obvious(P < 0.05).The hematoma volume was decreased,the treatment group decrease was more obvious(P <0.05).The total effective rate was 51.6% in the control group,and the total effective rate was 77.4%.There were significantly statistical differences between two groups(P < 0.05).Conclusion Nimodipine had a protective effect for brain damage in patients with cerebral hemorrhage,and could improve the nervous function and decrease hematoma volume,and it was a reliable drug.